NCT07727330
Pulsed Field Ablation for Ventricular Arrhythmias
StatusRecruiting
PhaseNot applicable
SponsorXi'an Jiaotong University
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 4 more changesShow less
- Eligibility criteria expanded, about 30 words
- Study sites: 0 to 1
- Start date changed from estimate of Jul 2026 to Oct 13, 2026
- Secondary endpoints: details revised at 4 of 8 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Immediate Procedural Success Rate
Timeframe: At the end of the ablation procedure, after a 30-minute post-ablation observation period
Treatment Success Rate at 6 Months After Ablation
Timeframe: 6 months after ablation
Secondary (8)
Total Procedure Time
Total Pulsed Field Ablation Delivery Time
Number of Pulsed Field Ablation Applications
Percentage of Participants With Death, Stroke, or Transient Ischemic Attack
Percentage of Participants With Procedure-Related Complications
Show 3 moreShow less
Percentage of Participants With Pulsed Field Ablation-Related Complications
Change From Baseline in EQ-5D-5L Index Score
Change From Baseline in SF-36 Score
Arms and interventions
Pulsed Field AblationExperimental
Participants with ventricular arrhythmias who meet the eligibility criteria will undergo pulsed field ablation using a disposable magnetic navigation and contact force-sensing pulsed field ablation catheter. The ablation target site, ablation strategy, and procedural endpoint will be determined by the investigator according to the type and origin of the ventricular arrhythmia, electroanatomical mapping findings, and standard clinical practice.
Procedures: Pulsed Field Ablation
Sites
1 site in 1 country
- The Second Affiliated Hospital of Xi'an Jiaotong UniversityXi'an, Shaanxi, China